Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.015 AUD | +15.38% | +25.00% | -37.50% |
05-01 | The Hydration Pharmaceuticals' Revenue Falls 14% in March Quarter | MT |
03-27 | The Hydration Pharmaceuticals Co. Secures AU$1.7 Million in Funding from Variation of Facility Agreement | MT |
Sales 2022 | 9.1M 13.77M 12.45M | Sales 2023 | 10.04M 15.2M 13.74M | Capitalization | 4.33M 6.56M 5.93M |
---|---|---|---|---|---|
Net income 2022 | -10M -15.13M -13.68M | Net income 2023 | -8M -12.11M -10.95M | EV / Sales 2022 | 0.99 x |
Net cash position 2022 | 976K 1.48M 1.34M | Net Debt 2023 | 2.05M 3.11M 2.81M | EV / Sales 2023 | 0.64 x |
P/E ratio 2022 |
-0.93
x | P/E ratio 2023 |
-0.39
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 69.37% |
1 day | +15.38% | ||
1 week | +25.00% | ||
Current month | +25.00% | ||
3 months | -16.67% | ||
6 months | -44.44% | ||
Current year | -37.50% |
Managers | Title | Age | Since |
---|---|---|---|
Oliver Baker
CEO | Chief Executive Officer | - | 17-12-31 |
Chris Kavanaugh
DFI | Director of Finance/CFO | - | 18-04-30 |
Victoria Nadalin
SEC | Corporate Secretary | - | 23-02-07 |
Members of the board | Title | Age | Since |
---|---|---|---|
Margaret Hardin
BRD | Director/Board Member | 51 | 22-02-07 |
Adem Karafili
BRD | Director/Board Member | - | 18-10-14 |
George Livery
CHM | Chairman | - | 21-11-01 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 0.015 | +15.38% | 114,241 |
24-05-01 | 0.013 | +8.33% | 415,738 |
24-04-29 | 0.012 | 0.00% | 45,000 |
Delayed Quote Australian S.E., May 01, 2024 at 09:10 pm
More quotes1st Jan change | Capi. | |
---|---|---|
-37.50% | 2.63M | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
+8.08% | 167B | |
-3.40% | 157B |
- Stock Market
- Equities
- HPC Stock